BMI_Logo-_NEW_2022.jpg

slogan2

301-378-2551
124 Byte Drive, Frederick, MD 21702

Contact Us Form

"Bringing Creativity to the Biomedical Industry"

Biological Mimetics, Inc. (BMI) welcomes you to our website. To use our websites, you are agreeing to comply with and be bound by the following terms, conditions of website use, which together with our privacy policy govern BMI’s relationship with you. If you disagree with any part of these terms and conditions, please do not use our website. BMI reserves the right to modify these terms, conditions, and disclaimers, along with the website content at any time, without notice.

The terms BMI or ‘us’ or ‘we’ refer to the owner of the website. The term ‘you’ refers to the user of our website.

Content Disclaimer

Some of the content of the website of BMI is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional advice.

We make no warranty or guarantee of any kind, as to the accuracy, completeness, reliability timeliness, performance, or suitability of the information and materials found or offered on this website for any particular purpose. By use of this site, you acknowledge that such information and materials may contain inaccuracies or errors.  

We do everything we can to keep our information up to date. However, at times, we will make changes to our information without notifying you, our visitor.

Limitation of Liability

You agree to hold harmless the BMI., its affiliates and their officers, directors, employees and volunteers, and web developers from all claims relating to our website and any website to which they are linked.

Third Party Information

Within our websites, there may be information by third parties. Your use of any information or materials on our website is entirely at your own risk, for which we shall not be liable.

Usage of Content and Copyright

Unless otherwise noted, all content and information contained on the BMI website such as text, graphics, and logos, is the property of and copyrighted by BMI. It may not be copied or used in whole or part without the express, written consent of BMI . Your use of this website and any dispute arising out of such use of the website is subject to the laws of the United States of America.

IRT_Logo.png IRT is the original platform technology identifies immunodominant highly divergent epitopes through bioinformatic analysis for dampening, which allows the immune system to ignore these decoy epitopes resulting in antibodies and cell-mediated responses to the more highly conserved less antigenic sites. HRV, Influenza and Covid-19 have all demonstrated improved immunogenicity using IRT.

ultraINACTIVATIONWith this patented technology pathogens are complexed with a manganese-decapeptide-phosphate (MDP) and then exposed to UV light. Advantages include a quick, easy, and reproducible process all while lowering manufacturing process costs. The MDP system has been adapted from radiation-resistant bacteria such as Deinococcus radiodurans. The front runner of this technology is ultraIPV. More information about ultraIPV can be found at https://bmi-vaccine.net

FastChipFAST is a convenient multi-chambered diagnostic tool that is pre-loaded during manufacturing with reaction components for simple, instrument-lt blue sq2free step-wise performance of CRISPR diagnostics. This technology was developed in collaboration with Dr. Ke Du, UC-Riverside and can be integrated with isothermal RPA amplification and CRISPR cleavage for instrument, yet sensitive nucleic acid detection compatible with emerging infections in low-income countries who are most devastated by these infections.

lt blue sq1For further information, please use our Contact Us Form

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok